Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-carbamoyl-2-acetamidobutanoic Acid
2. N(2)-acetylglutamine
3. 5817-09-4
4. N(sup2)-acetyl-l-glutamine
5. Chebi:73685
6. L-glutamine, N2-acetyl-
7. Ncgc00183120-01
8. Alpha-n-acetyl-l-glutamine;n2-acetylglutamine
9. Alpha-n-acetyl-l-glutamine
10. Dsstox_cid_28885
11. Dsstox_rid_83153
12. Dsstox_gsid_48959
13. Glutamine, N2-acetyl-, L- (8ci)
14. Glutamine, N-acetyl-
15. Cas-2490-97-3
16. Aceglutamidum [inn-latin]
17. Aceglutamida [inn-spanish]
18. Mfcd00038159
19. Nsc-186896
20. 2-acetamido-5-amino-5-oxopentanoic Acid
21. Bmse000145
22. Bmse001000
23. Schembl287577
24. Alpha-n-acetyl-glutamine
25. Chembl3184604
26. 4-carbamoyl-2-acetamidobutanoicacid
27. Tox21_113393
28. Nsc186896
29. Akos000159972
30. Akos016605458
31. Tox21_113393_1
32. Ncgc00344533-01
33. Sy057113
34. Db-046574
35. Ft-0629740
36. Ft-0629834
37. 2-(acetylamino)-5-amino-5-oxopentanoic Acid
38. En300-65857
39. Q-100009
40. Q4673064
41. Z85900147
42. 10b6e98f-2cb8-4d96-80d6-1cdc5541d3b2
| Molecular Weight | 188.18 g/mol |
|---|---|
| Molecular Formula | C7H12N2O4 |
| XLogP3 | -1.4 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 5 |
| Exact Mass | 188.07970687 g/mol |
| Monoisotopic Mass | 188.07970687 g/mol |
| Topological Polar Surface Area | 110 Ų |
| Heavy Atom Count | 13 |
| Formal Charge | 0 |
| Complexity | 227 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Aceglutamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aceglutamide, including repackagers and relabelers. The FDA regulates Aceglutamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aceglutamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Aceglutamide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Aceglutamide supplier is an individual or a company that provides Aceglutamide active pharmaceutical ingredient (API) or Aceglutamide finished formulations upon request. The Aceglutamide suppliers may include Aceglutamide API manufacturers, exporters, distributors and traders.
click here to find a list of Aceglutamide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Aceglutamide DMF (Drug Master File) is a document detailing the whole manufacturing process of Aceglutamide active pharmaceutical ingredient (API) in detail. Different forms of Aceglutamide DMFs exist exist since differing nations have different regulations, such as Aceglutamide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Aceglutamide DMF submitted to regulatory agencies in the US is known as a USDMF. Aceglutamide USDMF includes data on Aceglutamide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Aceglutamide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Aceglutamide suppliers with USDMF on PharmaCompass.
Aceglutamide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Aceglutamide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Aceglutamide GMP manufacturer or Aceglutamide GMP API supplier for your needs.
A Aceglutamide CoA (Certificate of Analysis) is a formal document that attests to Aceglutamide's compliance with Aceglutamide specifications and serves as a tool for batch-level quality control.
Aceglutamide CoA mostly includes findings from lab analyses of a specific batch. For each Aceglutamide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Aceglutamide may be tested according to a variety of international standards, such as European Pharmacopoeia (Aceglutamide EP), Aceglutamide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Aceglutamide USP).
LOOKING FOR A SUPPLIER?
